Good afternoon, As always, email us if you have any questions on any of the data or our takeaways - .
KEY CALL OUT
We'll run through the data and updates live on this afternoon's House Call, but for now, we see the Position Monitor stocks rotating around and largely "stuck" in a sort of shallow MicroQuad 3 position. This, combined w/ a the MacroQuad 2 backdrop, does help explain the overall performance we've observed/experienced. It looks like the consensus continues to wrestle with the outlook for 2022, as the Revision trend continues to reflect a bottoming in late 1Q22. With an uptick in COVID-19/Omicron cases (replacing Delta?) and #JPM2022 in January, could we see a peak in COVID cases coincide w/ a turn in estimates?
CLICK HERE for the full weekly update (our Sector Distillation deck).
ESTIMATE REVISION TRENDS
MICROQUADS*
Noteworthy this week:
MicroQuad 4 has a mix of larger-cap and COVID-comp names that could be great short candidates. See below.
As a reminder, if you have questions about the MicroQuad process, please try to find ~20 minutes to watch our Dec 30, 2020 call replay: Process & Utility of the Hedgeye Health Care #MicroQuads - CLICK HERE for event details (includes video link and materials link).
Position Monitor Stocks**
All data available upon request. Please reach out to with any feedback or inquiries.
Best,
Thomas Tobin
Managing Director
Twitter
LinkedIn
William McMahon
Analyst
Twitter
LinkedIn
Justin Venneri
Director, Primary Research
Twitter
LinkedIn
*Please note, not all Position Monitor names make it into the MicroQuad output - most likely due to a lack of sufficient historical trading and estimate data.
**We may show stocks that we have data for but the correlation fails to meet the criteria for MQ bin inclusion week-to-week.
